10.35
Schlusskurs vom Vortag:
$10.40
Offen:
$10.35
24-Stunden-Volumen:
7,483
Relative Volume:
0.17
Marktkapitalisierung:
$387.26M
Einnahmen:
$4.71M
Nettoeinkommen (Verlust:
$-46.77M
KGV:
-6.1619
EPS:
-1.6792
Netto-Cashflow:
$-60.34M
1W Leistung:
-1.74%
1M Leistung:
-4.46%
6M Leistung:
+22.45%
1J Leistung:
-32.15%
Nyxoah Sa Stock (NYXH) Company Profile
Vergleichen Sie NYXH mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
NYXH
Nyxoah Sa
|
10.35 | 387.26M | 4.71M | -46.77M | -60.34M | -1.6792 |
![]()
ISRG
Intuitive Surgical Inc
|
591.79 | 211.07B | 8.35B | 2.32B | 1.30B | 6.41 |
![]()
BDX
Becton Dickinson Co
|
227.43 | 65.30B | 20.64B | 1.73B | 2.94B | 6.02 |
![]()
ALC
Alcon Inc
|
90.31 | 44.67B | 9.76B | 1.16B | 665.00M | 2.34 |
![]()
RMD
Resmed Inc
|
231.69 | 34.04B | 4.93B | 1.25B | 1.38B | 8.47 |
![]()
COO
The Cooper Companies, Inc.
|
88.48 | 17.62B | 3.90B | 392.30M | 288.10M | 1.95 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2023-07-31 | Eingeleitet | H.C. Wainwright | Buy |
2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
2022-04-21 | Eingeleitet | Oppenheimer | Outperform |
2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
2021-12-21 | Fortgesetzt | Cantor Fitzgerald | Overweight |
2021-07-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Nyxoah Sa Aktie (NYXH) Neueste Nachrichten
(NYXH) On The My Stocks Page - Stock Traders Daily
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East - The Manila Times
Nyxoah (NASDAQ:NYXH) Stock Price Up 0.6%Here's What Happened - MarketBeat
Tri Pointe Homes (TPH) To Report Earnings Tomorrow: Here Is What To Expect - The Globe and Mail
Nyxoah (NASDAQ:NYXH) Shares Up 0.6% – Here’s What Happened - Defense World
Nyxoah to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Environmental Expert
(NYXH) Trading Report - Stock Traders Daily
Trend Tracker for (NYXH) - Stock Traders Daily
Cantor Fitzgerald Predicts Nyxoah FY2025 Earnings - Defense World
NYXHNyxoah SA Ordinary Shares Latest Stock News & Market Updates - StockTitan
Nyxoah Receives Transparency Notification from BlackRock - TipRanks
Publication relating to transparency notifications - GlobeNewswire
BlackRock Reduces Stake in Nyxoah Below 3% Threshold in Latest Holdings Update - StockTitan
Contrasting Nyxoah (NASDAQ:NYXH) and DarioHealth (NASDAQ:DRIO) - Defense World
(NYXH) Proactive Strategies - Stock Traders Daily
Retail investors are Nyxoah S.A.'s (EBR:NYXH) biggest owners and were rewarded after market cap rose by €38m last week - Simply Wall St
Nyxoah (NASDAQ:NYXH) Stock Price Up 1.2% – Here’s What Happened - Defense World
Nyxoah Receives Transparency Notification from BlackRock, Inc. - TipRanks
Nyxoah: The Future Of OSA (NASDAQ:NYXH) - Seeking Alpha
How the (NYXH) price action is used to our Advantage - Stock Traders Daily
BlackRock Takes 3% Stake in Medical Device Maker Nyxoah in Strategic Investment Move - StockTitan
Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024 - Finansavisen
(NYXH) Investment Analysis and Advice - Stock Traders Daily
Nyxoah's SWOT analysis: sleep apnea innovator faces growth hurdles - Investing.com
Nyxoah's SWOT analysis: sleep apnea innovator faces growth hurdles By Investing.com - Investing.com UK
Nyxoah introduces neurostimulator device for sleep apnoea in England - Yahoo Finance
Nyxoah's nerve stimulation device meets endpoints in sleep apnoea studyMedical Device Network - Oficjalny Portal Gminy Brzesko
HC Wainwright Reaffirms “Buy” Rating for Nyxoah (NASDAQ:NYXH) - Defense World
Nyxoah’s Genio Neurostimulator for OSA Launches in England - Sleep Review
Nyxoah's SWOT analysis: sleep apnea innovator's stock poised for US launch - Investing.com
Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England - GlobeNewswire
Nyxoah Announces Commercial Launch of Genio Innovative Therapy in England - Marketscreener.com
Where are the Opportunities in (NYXH) - Stock Traders Daily
Nyxoah Updates Share Capital and Voting Rights - TipRanks
Information on the Total Number of Voting Rights And Shares: Nyxoah - The Korea Bizwire
Information on the total number of voting rights and shares - GlobeNewswire
Objective long/short (NYXH) Report - Stock Traders Daily
Nyxoah (NASDAQ:NYXH) vs. Alpha Tau Medical (NASDAQ:DRTS) Head to Head Contrast - Defense World
Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference - The Korea Bizwire
Nyxoah to Present at Healthcare Conference Amidst Growth - TipRanks
Nyxoah to Present Sleep Apnea Innovation at Piper Sandler Healthcare Conference | NYXH Stock News - StockTitan
Nyxoah SA (NYXH) Reports Q3 Loss, Tops Revenue Estimates - MSN
Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024: Nyxoah - The Korea Bizwire
Nyxoah Schedules Special Meeting to Vote on EIB Loan Agreement Terms | NYXH Stock News - StockTitan
Publication Relating to Transparency Notifications: Nyxoah - The Korea Bizwire
Nyxoah’s Voting Rights Shift with ResMed Stake - TipRanks
ResMed's Stake in Nyxoah Drops Below 5% Threshold in Latest Holdings Update | NYXH Stock News - StockTitan
Publication relating to transparency notifications, Business Wires News - AsiaOne
Nyxoah S.A. (NASDAQ:NYXH) Short Interest Down 17.4% in October - MarketBeat
Finanzdaten der Nyxoah Sa-Aktie (NYXH)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):